A Daily GLP-1 Pill Could Curb Heavy Drinking
(gizmodo.com)
1.
2.
Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
(feeds.content.dowjones.io)
3.
AstraZeneca Says Wainua Trial Failed to Meet Primary Goal
(feeds.content.dowjones.io)
4.
5.
FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says
(feeds.content.dowjones.io)
6.
7.
Mazdutide versus placebo in Chinese adults with type 2 diabetes
(feeds.nature.com)
8.
Ozempic Pill Flops in Major Trials for Alzheimer’s
(gizmodo.com)
9.
Prozac 'no better than placebo' for treating children with depression, experts
(news.ycombinator.com)